Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

The symptoms asymmetry of drug-induced parkinsonism is not related to nigrostriatal cell degeneration: a SPECT-DaTSCAN study.

Gajos A, Dąbrowski J, Bieńkiewicz M, Płachcińska A, Kuśmierek J, Bogucki A.

Neurol Neurochir Pol. 2019;53(4):311-314. doi: 10.5603/PJNNS.a2019.0031. Epub 2019 Aug 23.

PMID:
31441498
2.

Readout of a dopant spin in the anisotropic quantum dot with a single magnetic ion.

Rodek A, Kazimierczuk T, Bogucki A, Smoleński T, Pacuski W, Kossacki P.

J Phys Condens Matter. 2019 Nov 13;31(45):455301. doi: 10.1088/1361-648X/ab33d9. Epub 2019 Jul 19.

PMID:
31323648
3.

Highly reduced penetrance in a family with a THAP1 nonsense mutation: Role of THAP1 expression?

Dulovic-Mahlow M, Gajos A, Baumann H, Pozojevic J, Kaiser FJ, Bogucki A, Lohmann K.

Parkinsonism Relat Disord. 2019 Aug;65:274-276. doi: 10.1016/j.parkreldis.2019.05.036. Epub 2019 May 25. No abstract available.

PMID:
31153764
4.

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A.

Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27.

5.

Should non-movement specialists refer patients for SPECT-DaTSCAN?

Gajos A, Dąbrowski J, Bieńkiewicz M, Płachcińska A, Kuśmierek J, Bogucki A.

Neurol Neurochir Pol. 2019;53(2):138-143. doi: 10.5603/PJNNS.a2019.0011. Epub 2019 Mar 11.

6.

Supramolecular Complexes of Graphene Oxide with Porphyrins: An Interplay between Electronic and Magnetic Properties.

Lewandowska K, Rosiak N, Bogucki A, Cielecka-Piontek J, Mizera M, Bednarski W, Suchecki M, Szaciłowski K.

Molecules. 2019 Feb 14;24(4). pii: E688. doi: 10.3390/molecules24040688.

7.

Optical fiber micro-connector with nanometer positioning precision for rapid prototyping of photonic devices.

Bogucki A, Zinkiewicz Ł, Pacuski W, Wasylczyk P, Kossacki P.

Opt Express. 2018 Apr 30;26(9):11513-11518. doi: 10.1364/OE.26.011513.

PMID:
29716069
8.

Robust autophagy in optic nerves of experimental Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease.

Liberski PP, Gajos A, Bogucki A.

Folia Neuropathol. 2017;55(4):289-294. doi: 10.5114/fn.2017.72386.

9.

Functional Evaluation of Small Fiber Pathways in Primary Restless Legs Syndrome: Aδ Pathway Study.

Fila M, Stasiołek M, Markiewicz A, Bogucki A.

J Clin Sleep Med. 2017 Dec 15;13(12):1455-1462. doi: 10.5664/jcsm.6848.

10.

Electron microscopic and confocal laser microscopy analysis of amyloid plaques in chronic wasting disease transmitted to transgenic mice.

Sikorska B, Gajos A, Bogucki A, Zielonka E, Sigurdson C, Liberski PP.

Prion. 2017 Nov 2;11(6):431-439. doi: 10.1080/19336896.2017.1384109.

11.

Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study.

Gajos A, Budrewicz S, Koszewicz M, Bieńkiewicz M, Dąbrowski J, Kuśmierek J, Sławek J, Bogucki A.

J Neural Transm (Vienna). 2017 Nov;124(11):1389-1393. doi: 10.1007/s00702-017-1780-1. Epub 2017 Aug 23.

12.

Generation of Low-Dimensional Architectures through the Self-Assembly of Pyromellitic Diimide Derivatives.

Musumeci C, Wałe Sa-Chorab M, Gorczyński A, Markiewicz G, Bogucki A, Świetlik R, Hnatejko Z, Jankowski W, Hoffmann M, Orgiu E, Stefankiewicz AR, Patroniak V, Ciesielski A, Samorì P.

ACS Omega. 2017 Apr 30;2(4):1672-1678. doi: 10.1021/acsomega.7b00286. Epub 2017 Apr 26.

13.

Comparison of magneto-optical properties of various excitonic complexes in CdTe and CdSe self-assembled quantum dots.

Kobak J, Smoleński T, Goryca M, Rousset JG, Pacuski W, Bogucki A, Oreszczuk K, Kossacki P, Nawrocki M, Golnik A, Płachta J, Wojnar P, Kruse C, Hommel D, Potemski M, Kazimierczuk T.

J Phys Condens Matter. 2016 Jul 6;28(26):265302. doi: 10.1088/0953-8984/28/26/265302. Epub 2016 May 13.

PMID:
27173643
14.

Unilateral progressive muscular atrophy with fast symptoms progression.

Bogucki A, Pigońska J, Szadkowska I, Gajos A.

Neurol Neurochir Pol. 2016;50(1):52-4. doi: 10.1016/j.pjnns.2015.10.009. Epub 2015 Nov 5.

PMID:
26851691
15.

The standard of urological consultation of patients qualified for renal transplant - a review.

Antoniewicz AA, Zapała Ł, Bogucki A, Małecki R.

Cent European J Urol. 2015;68(3):376-82. doi: 10.5173/ceju.2015.551. Epub 2015 Oct 15. Review.

16.

Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?

Hawro T, Bogucki A, Krupińska-Kun M, Maurer M, Woźniacka A.

Lupus. 2015 Dec;24(14):1492-7. doi: 10.1177/0961203315593818. Epub 2015 Jun 29.

PMID:
26124236
17.

Screening for THAP1 Mutations in Polish Patients with Dystonia Shows Known and Novel Substitutions.

Golanska E, Gajos A, Sieruta M, Szybka M, Rudzinska M, Ochudlo S, Kmiec T, Liberski PP, Bogucki A.

PLoS One. 2015 Jun 18;10(6):e0129656. doi: 10.1371/journal.pone.0129656. eCollection 2015.

18.

Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.

Hawro T, Bogucki A, Krupińska-Kun M, Maurer M, Woźniacka A.

PLoS One. 2015 Mar 17;10(3):e0119911. doi: 10.1371/journal.pone.0119911. eCollection 2015.

19.

High variability of clinical symptoms in a Polish family with a novel THAP1 mutation.

Gajos A, Golańska E, Sieruta M, Szybka M, Liberski PP, Bogucki A.

Int J Neurosci. 2015;125(10):755-9. doi: 10.3109/00207454.2014.981749. Epub 2014 Nov 11.

PMID:
25385508
20.
21.

Designing quantum dots for solotronics.

Kobak J, Smoleński T, Goryca M, Papaj M, Gietka K, Bogucki A, Koperski M, Rousset JG, Suffczyński J, Janik E, Nawrocki M, Golnik A, Kossacki P, Pacuski W.

Nat Commun. 2014;5:3191. doi: 10.1038/ncomms4191.

22.

[Apomorphine in advanced Parkinson disease].

Bogucki A.

Neurol Neurochir Pol. 2013 Sep-Oct;47(5):476-83. Review. Polish.

PMID:
24166569
23.

Guillain-Barré syndrome as the first manifestation of POEMS syndrome.

Sójka M, Gajos A, Pigońska J, Bogucki M, Tyfa K, Bogucki A.

Neurol Neurochir Pol. 2012 May-Jun;46(3):284-7.

PMID:
22773516
24.

Spectral optical coherence tomography in a patient with type I sialidosis.

Michalewska Z, Gajos A, Michalewski J, Nawrocki J, Pshezhetsky AV, Bogucki A.

Med Sci Monit. 2011 Oct;17(10):CS129-31.

25.

[Levodopa intestinal infusion therapy in Parkinson's disease].

Sławek J, Bogucki A.

Neurol Neurochir Pol. 2010 Jul-Aug;44(4):396-403. Review. Polish.

PMID:
20827613
26.

[Continuous dopaminergic stimulation - clinical experience].

Bogucki A, Sławek J.

Neurol Neurochir Pol. 2010 Jul-Aug;44(4):385-95. Review. Polish.

PMID:
20827612
27.

[Are botulinum toxin type A preparations really the same medication? A comparison of three botulinum toxin A for variations in labelled neurological indications].

Sławek J, Car H, Bonikowski M, Bogucki A, Koziorowski D, Potulska-Chromik A, Rudzińska M.

Neurol Neurochir Pol. 2010 Jan-Feb;44(1):43-64. Review. Polish.

PMID:
20358485
28.

The clinical and neuroimaging studies in Holmes tremor.

Gajos A, Bogucki A, Schinwelski M, Sołtan W, Rudzińska M, Budrewicz S, Koszewicz M, Majos A, Górska-Chrząstek M, Bieńkiewicz M, Kuśmierek J, Sławek J.

Acta Neurol Scand. 2010 Nov;122(5):360-6. doi: 10.1111/j.1600-0404.2009.01319.x.

PMID:
20078445
29.

[Laser evoked potentials as a method of evaluating the function of small fibres - application technique and clinical implications].

Fila M, Bogucki A.

Neurol Neurochir Pol. 2009 Jul-Aug;43(4):368-81. Review. Polish.

PMID:
19742396
30.

[Neurological disorders in systemic lupus erythematosus patients].

Hawro T, Bogucki A, Sysa-Jedrzejowska A, Bogaczewicz J, Woźniacka A.

Pol Merkur Lekarski. 2009 Jan;26(151):43-8. Polish.

PMID:
19391506
31.

Multifocal motor neuropathy with conduction block with sensory fibre involvement in a diabetic patient. Case report.

Fila M, Szadkowska I, Hasiec T, Bogucki A.

Neurol Neurochir Pol. 2008 May-Jun;42(3):267-73.

PMID:
18651334
32.

Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report.

Gajos A, Piaskowski S, Sławek J, Ochudło S, Opala G, Łobińska A, Honczarenko K, Budrewicz S, Koszewicz M, Pełszyńska B, Liberski PP, Bogucki A.

Neurol Neurochir Pol. 2007 Nov-Dec;41(6):487-94.

PMID:
18224570
33.

Impact of CT based attenuation correction on quantitative assessment of DaTSCAN ((123)I-Ioflupane) imaging in diagnosis of extrapyramidal diseases.

Bieńkiewicz M, Górska-Chrzastek M, Siennicki J, Gajos A, Bogucki A, Mochecka-Thoelke A, Płachcińska A, Kuśmierek J.

Nucl Med Rev Cent East Eur. 2008;11(2):53-8.

PMID:
19585455
34.

Spinal orthoses.

Bogucki A.

Ortop Traumatol Rehabil. 2002 Apr 30;4(2):237-43.

PMID:
18034090
35.

Upper limb prostheses.

Bogucki A.

Ortop Traumatol Rehabil. 2001 Apr 30;3(2):283-6.

PMID:
17987000
36.

Foot orthoses: therapeutic potential and technical aspects.

Bogucki A.

Ortop Traumatol Rehabil. 2001 Jan-Mar;3(1):120-5.

PMID:
17986974
37.

Orthoses of the upper limb.

Bogucki A.

Ortop Traumatol Rehabil. 2001 Jul-Sep;3(3):418-21.

PMID:
17984921
38.

Lower extremity prostheses.

Bogucki A.

Ortop Traumatol Rehabil. 2001;3(4):562-6.

PMID:
17984917
39.
40.

[Choosing a dopamine agonist in Parkinson's disease].

Bogucki A, Gajos A.

Neurol Neurochir Pol. 2007 Mar-Apr;41(2 Suppl 1):S14-21. Review. Polish.

PMID:
17941454
41.

Lower extremity orthoses.

Bogucki A.

Ortop Traumatol Rehabil. 2002 Jan 31;4(1):88-94.

PMID:
17679908
42.

[Stereotactic pallidotomy and thalamotomy in the treatment of primary dystonia].

Sławek J, Friedman A, Bogucki A, Opala G.

Neurol Neurochir Pol. 2007 Mar-Apr;41(2):188-9; author reply 190-1. Polish. No abstract available.

PMID:
17639636
43.

[Acquired peripheral neuropathies associated with monoclonal gammopathy].

Gajos A, Kieliś W, Szadkowska I, Chmielowska E, Niewodniczy A, Bogucki A.

Neurol Neurochir Pol. 2007 Mar-Apr;41(2):169-75. Polish.

PMID:
17530580
44.

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2.

Cébe Suarez S, Pieren M, Cariolato L, Arn S, Hoffmann U, Bogucki A, Manlius C, Wood J, Ballmer-Hofer K.

Cell Mol Life Sci. 2006 Sep;63(17):2067-77.

PMID:
16909199
45.

[Diagnostic methods of central nervous system changes in SLE patients].

Wozniacka A, Kusmierek J, Andrzejewska I, Pełka M, Sysa-Jedrzejowska A, Bogucki A.

Przegl Lek. 2005;62(5):306-9. Review. Polish.

PMID:
16334537
46.
47.

[Migraine with a combination of aura symptoms as a clinical manifestation of cortical spreading depression].

Gajos A, Jaworska-Chrebelska T, Bogucki A.

Neurol Neurochir Pol. 2005 Mar-Apr;39(2):163-5. Polish.

PMID:
15871063
48.

[Botulinum toxin type A in the management of spasticity in adults: recommendations of an interdisciplinary group of experts].

Sławek J, Bogucki A, Banach M, Członkowska A, Friedman A, Krawczyk M, Kwolek A, Opara J, Ochudło S, Zaborski J.

Neurol Neurochir Pol. 2004 Nov-Dec;38(6):443-5. Polish. No abstract available.

PMID:
15654667
49.

[Dopa-responsive dystonia (Segawa variant): clinical analysis of 7 cases with delayed diagnosis].

Sławek J, Friedman A, Bogucki A, Budrewicz S, Banach M.

Neurol Neurochir Pol. 2003;37 Suppl 5:117-26. Polish.

PMID:
15098338
50.

[The methods of hyperhidrosis treatment].

Woźniacka A, Bogucki A.

Pol Merkur Lekarski. 2003 Nov;15(89):495-7. Review. Polish.

PMID:
14969153

Supplemental Content

Loading ...
Support Center